Xeris Biopharma Holdings Inc (XERS) (Q3 2026) Earnings Call Highlights: Revenue Surges 44% as ...
Oppenheimer Reiterates Outperform on Xeris Biopharma Holdings, Raises Price Target to $21
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Q3 Beat and Raised Guidance Point to Stronger 2026
Loading...